ArticleJournal of thoracic disease2024
Preliminary exploration of poor prognostic factor IL-33 and its involvement in perioperative immunotherapy in stage II-III lung squamous cell carcinoma: a retrospective cohort study.
Yan Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.